Alendronate to prevent pelvic fractures in cervical cancer patients
Treatments studied
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests whether a medicine called alendronate can help prevent pelvic bone fractures in women with cervical cancer who are getting chemo-radiation. If you qualify, you may receive the study drug to strengthen your bones during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have cervical cancer (stage IB2 to IVA) that has not spread to other organs.
- You are scheduled to receive chemotherapy and radiation therapy (chemo-radiation).
- You have never had osteoporosis or taken bone medications like bisphosphonates.
- A recent scan (within the last 3 months) shows no cancer in your bones.
- You can sit or stand upright for at least 30 minutes (to take the study pill safely).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study wants to see if it is safe for postmenopausal women with osteoporosis to stop taking Alendronate after a long period of treatment without any new fractures. If you have been on Alendronate for a while and have stayed fracture-free, you may be able to take a break from the medicine.
This trial tests a combination of vitamin K, D-chiro inositol, and α-lactalbumin to help maintain bone strength in women with breast cancer who are on hormone therapy and have low vitamin D. It aims to see if these supplements improve bone health while you take a standard bone medication (alendronate).
This trial tests a way to reduce blood-related side effects from chemoradiation for locally advanced cervical cancer. It aims to make treatment safer and more tolerable.
This trial studies how the immune system responds to pelvic radiation therapy (with or without chemotherapy) in patients with cervical or other gynecologic cancers. It may help explain why some treatments work better and could lead to better treatments in the future.
This trial tests a combination of pelvic chemoradiation (chemotherapy and radiation) with a special type of brachytherapy (internal radiation) that adjusts the dose during treatment for locally advanced cervical cancer. It aims to improve tumor control while keeping side effects manageable.
This trial tests a shorter course of radiation combined with chemotherapy and brachytherapy (internal radiation) for cervical cancer that has not spread widely. It aims to make treatment more efficient while still being effective.
Hear when a new Cervix Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.